References
- 1. Harnack L, Jacobs DR, Nicodemus K, Lazovich D, Anderson K, Folsom AR. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002; 43:152-8.
- 2. Renkonen E, Lohi H, Jarvinen HJ, Mecklin JP, Peltomaki P. Novel splicing associations of hereditary colon cancer related DNA mismatch repair gene mutations. J Med Genet. 2004; 41:e95.10.1136/jmg.2003.017269
- 3. Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M, et al. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Cancer Chemother Pharmacol. 2002, 49: 445-52.
- 4. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004; 10:789-99.
- 5. Vogelsang M, Comino A, Zupanec N, Hudler P, Komel R. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast. BMC Cancer. 2009; 9:382.10.1186/1471-2407-9-382
- 6. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA. 2003; 100:776-81.10.1073/pnas.0334858100
- 7. Boland CR, Goel A. The silence of the genes: matching mismatch repair defects with tumors. Cancer. 2003; 98: 2091-4.10.1002/cncr.11769
- 8. Gallinger S, Aronson M, Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology. 2004; 126:576-85.
- 9. Liu J, Albarracin CT, Chang KH, Thompson-Lanza JA, Zheng W, Gershenson DM, et al. Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer. Mod Pathol. 2004; 17:75-80.
- 10. Zhang XM, Li JT, Zhu M, Wu XL, Gao P, Zhou P, et al. Study on the relationship between genetic polymorphism Va1384Asp in hMLH1 gene and risk of four different carcinomas. Chin J Epidemiology. 2004, 25:978-81.
- 11. Lipkin SM, Rozek LS, Rennert G, Yang W, Chen PC, Hacia J, et al. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet. 2004, 36:694-9.
- 12. Shin BY, Chen H, Rozek LS, Paxton L, Peel DJ, Anton- Culver H, et al. Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients. Dis Colon Rectum. 2005; 48:1723-7.
- 13. Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, EI Sharawy A, et al. Genetic investigation of DNArepair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 2007; 121:555-8.
- 14. Chaves P, Cruz C, Larg P, Cravo M, Leitao CN, Soares J. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol. 2000; 191:355-60.
- 15. Kim JC, Roh SA, Koo KH, Ka IH, Kim HC, Yu CS, et al. Genotyping possible polymorphic variants of human mismatch repair gene in healthy Korean individuals and sporadic colorectal cancer patients. Fam Cancer. 2004; 3:129-37.
- 16. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993; 260:812-6.
- 17. Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006; 56:213-25.
- 18. Mori S, Ogata Y, Shirouzu K. Biological features of sporadic colorectal carcinoma with high-freguency micrisatellite instability: special reference to tumor proliferation and apoptosis. Int J Clin Oncol. 2004; 9: 322-9.10.1007/s10147-004-0406-4
- 19. Chapusot C, Martin L, Mungra N, Rageot D, Bouvier AM, Bonithon Kopp C, et al. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: proteins and clinicopathological features of 273 adenocarcinomas. Histopathology. 2003; 43:40-47.
- 20. Rahner N, Friedrichs N, Steinke V, Aretz S, Friedl W, Buettner R, et al. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome. J Pathol. 2008; 214: 10-16.